Milestones in pathology—from histology to molecular biology

por Müllauer, Leonhard
Publicado 2017

Next generation sequencing: clinical applications in solid tumours

por Müllauer, Leonhard
Publicado 2017

Molecular Pathology of Cancer: The Past, the Present, and the Future

por Müllauer, Leonhard
Publicado 2021

Genomic alterations in thymoma—molecular pathogenesis?

por Oberndorfer, Felicitas, Müllauer, Leonhard
Publicado 2020

Systemic mastocytosis associated with chronic myelomonocytic leukemia and xanthogranuloma

por Tschandl, Philipp, Müllauer, Leonhard, Kittler, Harald
Publicado 2012

VARIFI—Web-Based Automatic Variant Identification, Filtering and Annotation of Amplicon Sequencing Data

por Krunic, Milica, Venhuizen, Peter, Müllauer, Leonhard, Kaserer, Bettina, von Haeseler, Arndt
Publicado 2019

Applied precision medicine in metastatic pancreatic ductal adenocarcinoma

por Taghizadeh, Hossein, Müllauer, Leonhard, Mader, Robert M., Schindl, Martin, Prager, Gerald W.
Publicado 2020

Molecularly guided treatment of metastatic parotid gland carcinoma in adults

por Taghizadeh, Hossein, Müllauer, Leonhard, Mader, Robert M., Füreder, Thorsten, Prager, Gerald W.
Publicado 2020

Application of mTORC1 Inhibitors for Tissue-Agnostic Management of Standard-Therapy-Refractory Solid Tumors

por Taghizadeh, Hossein, Maj-Hes, Agnieszka, Prager, Gerald W., Müllauer, Leonhard, Mader, Robert M.
Publicado 2022

PD-L1 Expression on Tumor Cells Is Associated With a Poor Outcome in a Cohort of Caucasian Nasopharyngeal Carcinoma Patients

por Minichsdorfer, Christoph, Oberndorfer, Felicitas, Krall, Christoph, Kornek, Gabriela, Müllauer, Leonhard, Wagner, Christina, Fuereder, Thorsten
Publicado 2019

HGG-44. DEFECTS OF MISMATCH REPAIR PROTEINS IN PEDIATRIC HIGH GRADE GLIOMAS

por Haberler, Christine, Muller, Philippe, Müllauer, Leonhard, Peyrl, Andreas, Czech, Thomas, Wimmer, Katharina, Slavc, Irene
Publicado 2020

Signet Ring Cell Carcinoma of the Lung: A Diagnostic Pitfall in Pregnancy

por Danzinger, Sabine, Köstler, Wolfgang J., Funovics, Martin, Herac, Merima, Müllauer, Leonhard, Prosch, Helmut, Kölbl, Heinz
Publicado 2019

Outcome of Targeted Therapy Recommendations for Metastatic and Recurrent Head and Neck Cancers

por Taghizadeh, Hossein, Mader, Robert M., Müllauer, Leonhard, Fuereder, Thorsten, Kautzky-Willer, Alexandra, Prager, Gerald W.
Publicado 2020

Precision Medicine for the Management of Therapy Refractory Colorectal Cancer

por Taghizadeh, Hossein, Mader, Robert M., Müllauer, Leonhard, Erhart, Friedrich, Kautzky-Willer, Alexandra, Prager, Gerald W.
Publicado 2020

Case Report: Afatinib Treatment in a Patient With NSCLC Harboring a Rare EGFR Exon 20 Mutation

por Zöchbauer-Müller, Sabine, Kaserer, Bettina, Prosch, Helmut, Cseh, Agnieszka, Solca, Flavio, Bauer, Markus Johann, Müllauer, Leonhard
Publicado 2021

Trabectedin Is Active against Two Novel, Patient-Derived Solitary Fibrous Pleural Tumor Cell Lines and Synergizes with Ponatinib

por Ghanim, Bahil, Baier, Dina, Pirker, Christine, Müllauer, Leonhard, Sinn, Katharina, Lang, Gyoergy, Hoetzenecker, Konrad, Berger, Walter
Publicado 2022

Reliability of Tumor Testing Compared to Germline Testing for Detecting BRCA1 and BRCA2 Mutations in Patients with Epithelial Ovarian Cancer

por Bekos, Christine, Grimm, Christoph, Kranawetter, Marlene, Polterauer, Stephan, Oberndorfer, Felicitas, Tan, Yen, Müllauer, Leonhard, Singer, Christian F.
Publicado 2021

Evaluation of efficacy of alemtuzumab in 5 patients with aplastic anemia and/or myelodysplastic neoplasm

por Füreder, Wolfgang, Cerny-Reiterer, Sabine, Sperr, Wolfgang R., Müllauer, Leonhard, Jäger, Eva, Schwarzinger, Ilse, Geissler, Klaus, Valent, Peter
Publicado 2016

Overweight as a Favorable Clinical Biomarker for Checkpoint Inhibitor Therapy Response in Recurrent Gynecologic Cancer Patients

por Bartl, Thomas, Onoprienko, Arina, Hofstetter, Gerda, Müllauer, Leonhard, Poetsch, Nina, Fuereder, Thorsten, Kofler, Paul, Polterauer, Stephan, Grimm, Christoph
Publicado 2021

Corrected Allele Frequency of BRCA1/2 Mutations Is an Independent Prognostic Factor for Treatment Response to PARP-Inhibitors in Ovarian Cancer Patients

por Grech, Christina T., Pils, Dietmar, Aust, Stefanie, Grimm, Christoph, Polterauer, Stephan, Reinthaller, Alexander, Müllauer, Leonhard, Reischer, Theresa, Bekos, Christine
Publicado 2022